Back to VA VANGUARD CAPITAL MANAGEMENT LLC
TRDA2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ENTRADA THERAPEUTICS INC
Yes. Vanguard Capital Management holds 1,269,634 shares of TRDA (Entrada Therapeutics), worth $9.3M, as of its Q2 2026 13F filing. It increased the position by 13,621 shares (+1.1%) from Q1 2026. Vanguard Capital Management has held TRDA in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$9.3M
Current Shares
1.3M
Total Value Change
-$6.5M
Total Shares Change
+13,621
Quarter-by-Quarter History
Other major holders of TRDA: BAKER BROS. ADVISORS LP